Yuyu Pharma (000220) — Cash Flow Reinvestment Rate
Yuyu Pharma (000220) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting ₩1.48 Billion (capex ₩1.46 Billion plus investments ₩-22.80 Million) from operating cash flow of ₩836.62 Million. See Yuyu Pharma free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yuyu Pharma Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Yuyu Pharma across 10 annual periods. For the full cash flow conversion analysis, see 000220 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Yuyu Pharma (2011–2024)
Year-by-year capital reinvestment analysis for Yuyu Pharma. See 000220 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.37x | ₩9.30 Billion | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.9% |
| 2023 | 17.93x | ₩7.55 Billion | ₩420.86 Million | ₩5.11 Billion | ▲ +1205.4% |
| 2021 | 1.37x | ₩6.19 Billion | ₩4.51 Billion | ₩6.07 Billion | ▲ +108.6% |
| 2019 | 0.66x | ₩8.68 Billion | ₩13.19 Billion | ₩8.06 Billion | ▼ -59.2% |
| 2018 | 1.61x | ₩9.87 Billion | ₩6.11 Billion | ₩9.76 Billion | ▼ -83.4% |
| 2017 | 9.74x | ₩5.46 Billion | ₩561.35 Million | ₩5.19 Billion | ▲ +2433.5% |
| 2016 | 0.38x | ₩3.77 Billion | ₩9.82 Billion | ₩2.32 Billion | ▼ -80.8% |
| 2014 | 2.00x | ₩2.73 Billion | ₩1.36 Billion | ₩404.37 Million | ▲ +1519.0% |
| 2012 | 0.12x | ₩805.15 Million | ₩6.51 Billion | ₩805.15 Million | ▲ +102.1% |
| 2011 | 0.06x | ₩408.49 Million | ₩6.67 Billion | ₩408.49 Million | — |